首页> 外文期刊>Saudi Journal of Anaesthesia >Ultrasound-guided bilateral superficial cervical plexus block for thyroid surgery: The effect of dexmedetomidine addition to bupivacaine-epinephrine
【24h】

Ultrasound-guided bilateral superficial cervical plexus block for thyroid surgery: The effect of dexmedetomidine addition to bupivacaine-epinephrine

机译:超声引导下双侧颈浅神经丛阻滞用于甲状腺手术:右美托咪定除布比卡因-肾上腺素外的作用

获取原文
           

摘要

Background: The thyroid gland surgery is a common and painful procedure demanding analgesia. Many regional techniques are applied for anterior neck surgeries mostly assigned in relation to the involved cervical fascia. Dexmedetomidine (Precedex) is a selective alpha 2 adrenoceptor agonist which prolongs the sensory blockade duration of local anesthetics. Our study hypothesis is that ultrasound (US)-guided bilateral superficial cervical plexus block (BSCPB) may provide longer analgesia when adding dexmedetomidine to bupivacaine-epinephrine. Purpose: The aim of this study is to evaluate the analgesic efficacy and possible side effects of US-guided BSCPB and the effect of dexmedetomidine addition to bupivacaine-epinephrine in patients undergoing thyroid surgery. Methods: This prospective, double-blind, randomized study was performed on 42 patients randomized into two equal groups each of 21; bupivacaine Group B and dexmedetomidine Group D. Patients with contraindications to regional anesthesia or uncontrolled comorbidities were excluded from the study. Total pethidine consumption in 24 h is the primary outcome. The visual analog scale, timing of the first opioid request, and hemodynamics are the secondary outcomes. Results: In Group D, there was a longer time to the first request of opioid postoperatively, a lower total pethidine consumption and pain score postoperatively, and lower fentanyl requirements intraoperatively. Conclusions: Sonographic-guided bilateral SCPB using a combination of bupivacaine, dexmedetomidine, and epinephrine was superior to bupivacaine for prolonged analgesia with less intra- and postoperative opioid consumption and lower side effect profile during thyroid surgery.
机译:背景:甲状腺手术是一种常见且痛苦的过程,需要镇痛。许多区域性技术被应用于前颈部手术,这些手术大多与受累颈筋膜有关。右美托咪定(Precedex)是一种选择性的α2肾上腺素受体激动剂,可延长局部麻醉剂的感觉阻滞时间。我们的研究假设是,当在布比卡因-肾上腺素中添加右美托咪定时,超声(美国)引导的双侧颈浅神经丛阻滞(BSCPB)可能会提供更长的镇痛作用。目的:本研究的目的是评估在甲状腺手术患者中美国指导的BSCPB的镇痛效果和可能的副作用以及在布比卡因-肾上腺素中右美托咪定的作用。方法:这项前瞻性,双盲,随机研究针对42例患者进行,随机分为两组,每组21个;布比卡因B组和右美托咪定D组。区域麻醉禁忌症或合并症未得到控制的患者被排除在研究之外。主要的结果是24小时内的总哌替啶消耗量。视觉模拟量表,首次使用阿片类药物的时间以及血液动力学是次要结果。结果:D组术后首次使用阿片类药物的时间较长,术后总哌替啶消耗量和疼痛评分较低,术中芬太尼需求较低。结论:结合布比卡因,右美托咪定和肾上腺素的超声引导下双侧SCPB在延长镇痛方面优于布比卡因,在甲状腺手术中减少了术中和术后阿片类药物的消耗,并降低了副作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号